
Predictors of intracerebral hemorrhage in acute stroke patients receiving intravenous recombinant tissue plasminogen activator
Author(s) -
Vijay Chenna,
Subhash Kaul,
Swetha Tandra,
Sireesha Yareeda,
Neeharika L Mathukumalli,
Abhijeet Kumar Kohat,
Rukmini Mridula Kandadai,
Suryaprabha Turaga,
Jabeen Afshan Sheik,
A K Meena,
Rupam Borgohain
Publication year - 2018
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_228_17
Subject(s) - medicine , thrombolysis , intracerebral hemorrhage , recombinant tissue plasminogen activator , tissue plasminogen activator , diabetes mellitus , stroke (engine) , complication , gastroenterology , t plasminogen activator , ischemic stroke , surgery , ischemia , myocardial infarction , subarachnoid hemorrhage , endocrinology , modified rankin scale , mechanical engineering , engineering
Symptomatic Intracerebral hemorrhage (sICH) is a serious complication of recombinant tissue-plasminogen activator (rt-PA) therapy for acute ischemic stroke (AIS).